Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier

Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier

Purpose: Evidence for optimizing the first-line chemotherapy for patients with metastatic triple-negative breast cancer (mTNBC) is lacking. This study assessed the utilization patterns of chemotherapy and associated survival outcomes in de novo mTNBC patients. Methods: Taiwan's cancer registry...

Full description

Bibliographic Details
Main Authors: Wei-Pang Chung, Chun-Ting Yang, Hsuan-Ying Chen, Ching-Yen Su, Hsin-Wei Su, Huang-Tz Ou
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Journal of the Formosan Medical Association
Subjects:
Age
Chemotherapy
Survival
Triple-negative breast cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664621001856

Similar Items

Similar Items